v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
CASH USED IN OPERATING ACTIVITIES    
Net income (loss) $ 122 $ (3,516)
Adjustments to reconcile net income (loss) to cash used in operating activities:    
Share-based compensation 959 1,767
Amortization of intangible assets 1,076 1,076
Depreciation 2,009 1,552
Excess of fair value of warrants over proceeds of private placement 439 1,040
Change in fair value of warrant liability (16,493) (13,229)
Gain/Loss on warrants modification 2,442 0
Changes in assets and liabilities:    
Accounts receivable (138) (337)
Inventory 0 (1,061)
Prepaid expenses 22 62
Lease liability 2 1
Trade payables and other liabilities (107) (810)
Net cash used in operating activities (9,667) (13,455)
CASH USED IN INVESTING ACTIVITIES    
Purchase of equipment (401) (1,328)
Net cash used in investing activities (401) (1,328)
CASH PROVIDED BY FINANCING ACTIVITIES    
Proceeds from private placement of shares and warrants 9,000 24,417
Share issuance costs (482) (602)
Subscription received for private placement 0 679
Net cash provided by financing activities 8,518 24,494
Net change in cash (1,550) 9,711
Beginning cash balance 10,737 1,026
Ending cash balance 9,187 10,737
Supplemental disclosures of non-cash transactions:    
Equipment purchases included in trade payables 0 (119)
Share issuance costs for common shares issued 0 188
Shares issued for debt settlement 679 0
Value of common shares issued share issuance costs 0 1,005
Private placement proceeds allocated to warrant liability 8,428 22,972
Accounts receivable settled through share cancellation $ 75 $ 0